DrugPatentWatch Database Preview
XYOSTED (AUTOINJECTOR) Drug Profile
Which patents cover Xyosted (autoinjector), and when can generic versions of Xyosted (autoinjector) launch?
Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. There are nine patents protecting this drug.
This drug has forty-three patent family members in twelve countries.
The generic ingredient in XYOSTED (AUTOINJECTOR) is testosterone enanthate. There are sixty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the testosterone enanthate profile page.
Summary for XYOSTED (AUTOINJECTOR)
| International Patents: | 43 |
| US Patents: | 9 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for XYOSTED (AUTOINJECTOR) |
| DailyMed Link: | XYOSTED (AUTOINJECTOR) at DailyMed |
-patent-expirations.png "XYOSTED (AUTOINJECTOR) drug patent expirations")
US Patents and Regulatory Information for XYOSTED (AUTOINJECTOR)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-003 | Sep 28, 2018 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-003 | Sep 28, 2018 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-001 | Sep 28, 2018 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-002 | Sep 28, 2018 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-003 | Sep 28, 2018 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for XYOSTED (AUTOINJECTOR)
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2016507305 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 0009186 | ➤ Try a Free Trial |
| Australia | 5470499 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2014124427 | ➤ Try a Free Trial |
| South Korea | 20140050663 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
